Question · asked by 1 review
MSCs vs placebo or control: Health‐related quality of life
- Population
- patients with a haematological condition who receive a haematopoietic stem cell transplant as treatment for their condition.
- Intervention
- MSCs
- Comparison
- placebo or control
- Outcome
- Health‐related quality of life
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
MSCs vs control/placebo Health‐related quality of life · patients with a haematological condition who receive a haematopoietic stem cell transplant as treatment for their… The review found no eligible studies for this question. Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in… (2019) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Mesenchymal stromal cells as treatment or prophylaxis for acute or chronic graft‐versus‐host disease in haematopoietic stem cell… 2019 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.